Our results indicate that the strategy of combining NSC-124854 with TMZ seems to be effectively blocking the growth of both MMR-proficient and MMR-deficient colon cancer cells in vitro and causing anti-tumor activity in vivo, which supports the previous findings [27], [59]. The gene discussed is MRC1; the disease is neoplasm.